(IN BRIEF) The Institute of Cancer Research has welcomed Sutton Council’s approval of ambitious plans led by Aviva Capital Partners and Socius to create around one million square feet of new life-sciences research and laboratory space across a 12-acre site … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Insurance, Investment, Management, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Aviva Capital Partners, cancer research, Daniel May, economic growth, high-skilled jobs, ICR, ICR Welcomes Approval of New One-Million-Square-Foot Life-Sciences Campus at The London Cancer Hub, Innovation Gateway, Institute of Cancer Research, Kristian Helin, laboratory space, life sciences, London Borough of Sutton, research and development, science infrastructure, Socius, Sophie White, Sutton, The London Cancer Hub, The Royal Marsden NHS Foundation Trust
(IN BRIEF) Krka has been recognised as Slovenia’s leading company in the 2025 Business Excellence survey conducted by Ninamedia, ranking first among 54 companies according to both business representatives and the general public based on evaluations of visibility, performance, reputation, … Read the full press release
Posted in Awards, Business, Environment, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Slovenia, Technology
Tagged business performance, company visibility, Corporate Leadership, corporate reputation, INNOVATION, international expansion, Jože Colarič, Krka, Krka Recognised as Slovenia’s Leading Company in 2025 Business Excellence Survey by Ninamedia, Ninamedia, pharmaceutical industry, Slovenian business excellence, Slovenian exporters, sustainability
(IN BRIEF) The European Association of Percutaneous Cardiovascular Interventions will hold its first official summit under the European Society of Cardiology in Munich on 19–20 February 2026, bringing together leading and emerging specialists in interventional cardiology to focus on education, … Read the full press release
Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Alaide Chieffo, cardiology education, Cardiovascular Imaging, catheter-based procedures, clinical guidelines, EACTS, EAPCI, ESC, ESC and EAPCI convene multidisciplinary summit to shape the future of catheter-based cardiovascular care, European Society of Cardiology, heart failure, Heart Team, interventional cardiology, Medical Device Regulation, Munich, patient-centred care, PCI, percutaneous cardiovascular interventions, simulator training, TAVI, Thomas F. Lüscher, young professionals
(IN BRIEF) Sanofi has received a positive recommendation from the European Medicines Agency’s CHMP for the conditional approval of Rezurock to treat late-line chronic graft-versus-host disease in adults and adolescents aged 12 and older. The opinion, based on clinical trial … Read the full press release
Posted in European Union, France, Healthcare, Marketing, Pharma & Biotech
Tagged belumosudil, CHMP, CHMP Recommends Conditional EU Authorisation for Sanofi’s Rezurock to Treat Late-Line Chronic GVHD, chronic graft-versus-host disease, clinical trials, conditional marketing authorisation, EU regulatory approval, European Medicines Agency, GVHD, haematology, rare diseases, Rezurock™, ROCK2 inhibitor, ROCKstar study, Sanofi, stem cell transplant
(IN BRIEF) The University of Liverpool and the University of Medicine and Pharmacy at Ho Chi Minh City have signed a Memorandum of Understanding establishing a long-term partnership focused on data science and artificial intelligence innovation for healthcare. Signed during … Read the full press release
Posted in Artificial Intelligence (AI), Education, Healthcare, Internet & Online, Pharma & Biotech, Science, Technology, United Kingdom
Tagged academic partnership, artificial intelligence, biomedical informatics, Civic Health Innovation Labs, data science, Department of Public Health Policy and Systems, digital health, Faculty of Health and Life Sciences, health systems resilience, Healthcare Innovation, Institute of Population Health, Liverpool City Council, Liverpool City Region, Memorandum of Understanding, public health research, UK Vietnam collaboration, UMP HCMC, University of Liverpool Strengthens UK–Vietnam Health Innovation Ties Through AI-Focused Collaboration with UMP HCMC University of Liverpool, University of Medicine and Pharmacy at Ho Chi Minh City
(IN BRIEF) AstraZeneca has announced a $15 billion investment in China through 2030 to expand research, development and manufacturing capabilities, supporting its long-term growth strategy and global pipeline in advanced treatment modalities such as cell therapy and radioconjugates. The investment … Read the full press release
Posted in Business, Healthcare, Investment, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged advanced medicines, AstraZeneca, AstraZeneca Accelerates 2030 Strategy with $15 Billion China Investment in Breakthrough Therapies and Manufacturing, biopharmaceutical expansion, cell therapy, China investment, China UK healthcare collaboration, global R&D centres, healthcare ecosystem, Healthy China 2030, Keir Starmer, life sciences strategy, oncology innovation, Pascal Soriot, pharmaceutical manufacturing, radioconjugates, research and development
(IN BRIEF) CERSI-PGx has launched a free eLearning portal to support the adoption of pharmacogenomics in routine clinical practice. Led by the University of Liverpool in partnership with the British Pharmacological Society and Queen Mary University of London, the platform … Read the full press release
Posted in Education, Healthcare, Internet & Online, Pharma & Biotech, Science, Technology, United Kingdom
Tagged British Pharmacological Society, CERSI PGx, eLearning portal, Faculty of Health and Life Sciences, genomic guided prescribing, genomic medicine, healthcare education Department of Pharmacology and Therapeutics, Innovate UK, Institute of Systems Molecular and Integrative Biology, Maria Tsakiroglou, New CERSI-PGx eLearning Platform Aims to Equip Healthcare Professionals for Genomic-Guided Prescribing, NHS genomics, personalised medicine, pharmacogenomics, Queen Mary University of London, regulatory science, Sir Munir Pirmohamed, Therapeutics Innovation, University of Liverpool
(IN BRIEF) Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental glomerulosclerosis. Published in The Lancet, the study showed a 40% reduction in proteinuria … Read the full press release
Posted in Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged apecotrep BI 764198, Boehringer Ingelheim, Boehringer Ingelheim Advances Targeted Kidney Disease Pipeline with Promising Phase II Data for Apecotrep in FSGS, FSGS, Howard Trachtman, kidney disease research, non immunosuppressive therapy, Paola Casarosa, Phase II clinical trial, Phase III clinical development, podocyte protection, primary focal segmental glomerulosclerosis, proteinuria reduction, rare kidney diseases, renal disease innovation, TRPC6 inhibitor
(IN BRIEF) The Institute of Cancer Research, London, has led the development of OPTIMISE-ROR, the first structured guidance outlining how patient-reported outcomes should be used in early-stage cancer dose-finding trials. Published in the Journal of Clinical Oncology, the recommendations provide … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer Research UK, Christina Yap, clinical trials methodology, dose-finding studies, early-stage cancer trials, Emily Alger, Experimental Cancer Medicine Centre, ICR, Institute of Cancer Research Develops First Foundational Framework for Patient-Reported Outcomes in Early Oncology Trials, Institute of Cancer Research London, International Study Led by ICR Strengthens Role of Patient Experience in Early-Phase Cancer Drug Development, Journal of Clinical Oncology, oncology research, OPTIMISE-ROR, patient-reported outcomes, PROs
(IN BRIEF) ISS has been awarded a full Integrated Facilities Services contract by a major life sciences and pharmaceutical company in Switzerland, with an annual value of close to DKK 300 million. The agreement expands ISS’s role from subcontractor to … Read the full press release
Posted in Business, Denmark, Industrial, Infrastructure & Utilities, Management, News, Pharma & Biotech, Switzerland, Technology
Tagged André Nauer, cleaning services, digital solutions, facilities management, Integrated Facilities Services, ISS, ISS Awarded DKK 300 Million Facilities Management Contract in Swiss Life Sciences Sector, ISS Expands Swiss Operations with New Integrated Facilities Services Agreement, ISS Switzerland, laboratory services, life sciences, logistics services, maintenance repair and operations, pharmaceutical company, Switzerland, technical services, Workplace Support
(IN BRIEF) The Institute of Cancer Research has welcomed NICE’s recommendation of talazoparib in combination with enzalutamide for adults with metastatic prostate cancer, providing a new treatment option for around 2,400 patients in England who are unsuitable for chemotherapy. Backed … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged BRCA mutations, DNA repair gene mutations, enzalutamide, Institute of Cancer Research London, metastatic prostate cancer, NICE recommendation, NICE Recommendation of Talazoparib Marks New Treatment Option for Advanced Prostate Cancer, PARP inhibitors, prostate cancer treatment, Royal Marsden NHS Foundation Trust, TALAPRO trials, talazoparib, Talzenna, targeted cancer therapy
(IN BRIEF) GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy approved for both conditions in … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged asthma treatment China, CAPTAIN study, chronic respiratory disease, COPD treatment, FF UMEC VI, GSK, GSK Expands Respiratory Portfolio in China with Asthma Approval for Trelegy Ellipta, inhaled therapy, National Medical Products Administration, respiratory medicine, single inhaler triple therapy, Trelegy Ellipta, uncontrolled asthma
(IN BRIEF) Rīga Stradiņš University (RSU) will host the BFCS 2026 international conference on 19–20 March 2026 in Riga, Latvia, in collaboration with the Baltic Flow Cytometry Society. The two-day event will bring together flow cytometry specialists, clinicians, and researchers … Read the full press release
Posted in Education, Healthcare, Latvia, Pharma & Biotech, Science, Technology
Tagged abstract submission, Baltic Flow Cytometry Society, BFCS, BFCS 2026, biomedical research, clinical research, early-career researchers, flow cytometry, immunology, Institute of Microbiology and Virology, interdisciplinary collaboration, international scientific conference, microbiology, oncology, PhD students, postdoctoral fellows, Riga Latvia, Rīga Stradiņš University, RSU, scientific networking, virology, Young Researcher Awards
(IN BRIEF) EMA has appointed Carmen Purdel as the new Chair of the Committee for Herbal Medicinal Products, with a three-year mandate starting on 2 March 2026. A long-standing member of the committee since 2011, Purdel brings regulatory and academic … Read the full press release
Posted in European Union, Healthcare, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Carmen Purdel, Carmen Purdel Named Chair of EMA’s Herbal Medicinal Products Committee, Carmen Purdel to Lead EMA Committee for Herbal Medicinal Products From March 2026, Committee for Herbal Medicinal Products, EMA, Emiel van Galen, EU medicines regulation, European Medicines Agency, herbal medicinal products, HMPC, Medicines Evaluation Board, National Agency for Medicines and Medical Devices Romania, Real-World Data, regulatory harmonisation, traditional herbal medicines, University of Medicine and Pharmacy Bucharest
(IN BRIEF) DNV has certified Clearlab’s contact lenses and multi-purpose lens care solutions under the Medical Device Single Audit Program, ISO 13485, and the EU Medical Device Regulation through a parallel audit process. This integrated approach enabled Clearlab to achieve … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Norway, Pharma & Biotech, Technology
Tagged Asia Pacific, Clearlab, contact lenses, DNV, DNV Certifies Clearlab Contact Lens Products Under Global Medical Device Standards, DNV Completes Parallel Audit for Clearlab Contact Lenses and Lens Care Solutions, EU MDR 2017/745, Europe, Global market access, ISO 13485, lens care solutions, MDSAP, medical device certification, Medical Device Regulation, medical devices, parallel audit, patient safety, quality management systems, regulatory compliance
(IN BRIEF) Empa has developed polymer-based, MRI-compatible electrode cables in collaboration with Swiss company TI Solutions AG, addressing long-standing safety and performance challenges associated with using conductive materials inside MRI scanners. By replacing traditional copper wiring with polymer fibers coated … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Advanced Fibers laboratory, diagnostic technology, Dirk Hegemann, ECG, EEG, Empa, Empa Introduces Scalable Polymer Fiber Cables Designed for Safe Use in MRI Environments, Innosuisse, magnetic resonance imaging, magnetron sputtering, medical imaging, medical research, MRI, MRI-compatible cables, neurostimulation, Niels Kuster, polymer cables, silver titanium coating, Sven Kühn, temporal interference stimulation, TI Solutions AG
(IN BRIEF) EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, led through the LSP Dementia … Read the full press release
Posted in Healthcare, Investment, Pharma & Biotech, Sweden
Tagged agitation, Alzheimer’s disease, Andera Partners, dementia care, Deraphan, EQT Life Sciences, Exciva, Exciva Raises €51 Million Series B to Support Phase 2 Trial for Alzheimer’s Agitation Treatment, Fountain Healthcare Partners, Gimv, Juliette Lee, LBBW, LifeArc, LSP Dementia Fund, neuropsychiatric symptoms, neuroscience therapeutics, Phase 2 clinical trial, Philip Scheltens, Series B financing
(IN BRIEF) GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, while GSK maintains a 78.3 percent majority holding. The transaction, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biopharma partnership, cabotegravir, David Redfern, dolutegravir, GSK, HIV prevention, HIV treatment, integrase inhibitors, John Keller, long acting injectables, Pfizer, pharmaceutical industry, shareholder restructuring, Shionogi, strategic investment, ViiV Healthcare, ViiV Healthcare Ownership Streamlined with Expanded Shionogi Investment and GSK Majority
(IN BRIEF) GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its Respiratory, Immunology & Inflammation pipeline. Designed to offer sustained … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged anti IgE therapy, biopharmaceutical acquisition, Brian Wong, clinical-stage biotech, Food allergy, GSK, GSK Expands Food Allergy Portfolio with Acquisition of RAPT and Ozureprubart Asset, Healthcare Innovation, immunology, monoclonal antibody, ozureprubart, pediatric allergy, phase IIb trial, prestIgE study, RAPT Therapeutics, respiratory and inflammation pipeline, Tony Wood
(IN BRIEF) Fresenius and SAP have announced plans to form a strategic partnership to accelerate digital innovation in healthcare and establish a sovereign, interoperable, and AI-supported healthcare ecosystem. By combining Fresenius’ global healthcare expertise with SAP’s digital platforms and AI … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI in healthcare, AnyEMR, Christian Klein, data sovereignty, digital healthcare, digital transformation, electronic medical records, European healthcare innovation, Fresenius, HL7 FHIR, hospital information systems, interoperable healthcare systems, Michael Sen, SAP, SAP Business AI, SAP Business Data Cloud, SAP Business Suite, SAP Business Technology Platform, Strategic Fresenius–SAP Collaboration Targets AI-Supported Healthcare Transformation, strategic partnership
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?